Karl Herholz
Affiliations: | University of Manchester, Manchester, England, United Kingdom |
Google:
"Karl Herholz"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kübler D, Kobylecki C, McDonald KR, et al. (2023) Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease. Parkinsonism & Related Disorders. 107: 105277 |
Tomassen J, den Braber A, van der Lee SJ, et al. (2022) Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score. Bmc Neurology. 22: 484 |
Michalowska MM, Herholz K, Hinz R, et al. (2022) Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78-94. Molecular Psychiatry |
Herholz K. (2022) Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer's Disease. Brain Sciences. 12 |
Chételat G, Arbizu J, Barthel H, et al. (2020) Amyloid-PET and F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet. Neurology. 19: 951-962 |
Mada MO, Hindmarch P, Stirling J, et al. (2020) Competencies and training of radiographers and technologists for PET/MR imaging - a study from the UK MR-PET network. European Journal of Hybrid Imaging. 4: 1 |
Herholz K. (2020) Hide-and-seek for radiotracers and neurodegenerative pathology. European Journal of Nuclear Medicine and Molecular Imaging |
Carter SF, Herholz K, Rosa-Neto P, et al. (2019) Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine |
Asghar M, Hinz R, Herholz K, et al. (2019) Dual-phase [18F]florbetapir in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 46: 304-311 |
Legdeur N, Badissi M, Carter SF, et al. (2018) Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. Bmc Geriatrics. 18: 289 |